journal article·2025-03

Surfactant mediated intercalation of a hydrophobic drug into layered double hydroxides: Probing the structural features by the photophysical behaviour of piroxicam

Nawal Fodil Cherif, François Réveret, Anthony Barros, Vagner Roberto Magri, Fabrice Leroux, Damien Boyer, Vera Regina Leopoldo Constantino, Christine Taviot-Guého

Publisher page

Abstract

Piroxicam (PIR), a hydrophobic drug with ionisable properties, can adopt various prototropic forms and conformations, which make its structural and dynamic properties highly dependent on its environment. In this study, PIR was, for the first time, incorporated into Zn 2+/Al 3+ layered double hydroxides using a surfactant-mediated intercalation method (Zn 2Al-DS @%PIR), which first involved the encapsulation of PIR within dodecyl sulfate (DS) micelles. A comprehensive investigation of the DS-PIR assembly within the interlayer space of the LDH is proposed, particularly emphasizing the utilization of the optical properties of PIR as a structural probe. The structural and chemical properties of the Zn 2Al-DS @%PIR samples prepared with different PIR contents (0.16, 0.90 and 2.06 wt%) were assessed by X-ray diffraction, Fourier transform infrared (FTIR) and thermal analysis. By exploiting PIR`s photochemical properties in both solid-state and solution, it was gained deeper insights into PIR molecular arrangement within the LDH interlayer space. FTIR results showed the stabilization of the ZZZ conformation form for intercalated PIR, while thermal analyses revealed an improved thermal stability of PIR of 80 °C for the sample with a maximum PIR loading content of 2.06 wt%. Interestingly, fluorescence results clearly confirmed the intercalation of PIR in LDH, both as global neutral and anionic forms, and allowed to infer their location in the interlayer space. A protective effect against photodegradation was also observed. This work can contribute to advancements in the challenging intercalation of other hydrophobic drugs.
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · Advanced Photocatalysis Techniques · Covalent Organic Framework Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (75)

Show source-provided references
1. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate10.1016/j.ejps.2007.07.005 ↗
2. Montmorillonite as an agent for drug photostability10.1039/c2jm34120d ↗
3. Advanced drug delivery applications of layered double hydroxide10.1016/j.jconrel.2020.12.041 ↗
4. The influence of water on the photophysical and photochemical properties of piroxicam in AOT/iso-octane/water reversed micelles10.1562/0031-8655(2000)0710405TIOWOT2.0.CO2 ↗
5. Polysaccharides based gastroretentive system to sustain piroxicam release: Development and in vivo prolonged anti-inflammatory effect10.1016/j.ijbiomac.2018.08.140 ↗
6. Spectroscopic studies of microenvironment dictated structural forms of piroxicam and meloxicam
7. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam10.1016/S1386-1425(02)00300-1 ↗
8. Importance of tautomerism in drugs10.1016/j.drudis.2023.103494 ↗
9. Piroxicam monohydrate: a Zwitterionie form, C15H13N3O4S.H2O
10. Piroxicam: a review of its pharmacological properties and therapeutic efficacy10.2165/00003495-198122030-00001 ↗
11. The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors10.2147/DDDT.S84849 ↗
12. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)10.1007/BF03261999 ↗
13. Interaction of piroxicam with micelles: effect of hydrophobic chain length on structural switchover10.1016/j.bpc.2005.04.016 ↗
14. Effect of counterion on the structural switchover and binding of piroxicam with sodium dodecyl sulfate (SDS) micelles10.1016/j.jcis.2005.05.056 ↗
15. Incorporation of NSAIDs in micelles: implication of structural switchover in drug–membrane interaction10.1016/S0301-4622(02)00389-7 ↗
16. Cocrystals of piroxicam with carboxylic acids10.1021/cg060742p ↗
17. Intercalation of dodecyl sulfate into layered double hydroxides10.1007/BF01041414 ↗
18. Mechanism of surfactant micelle formation10.1021/la801705y ↗
19. Phytochemical species intercalated into layered double hydroxides: structural investigation and biocompatibility assays10.1039/D0NJ00238K ↗
20. European Medicines Agency · 2017
21. Advances in drug delivery systems, challenges and future directions10.1016/j.heliyon.2023.e17488 ↗
22. Forano · 2013 · 745
23. Critical micelle concentration of surfactants in aqueous buffered and unbuffered systems10.1016/j.aca.2005.05.069 ↗
24. Influence of cyclodextrins on the photostability of selected drug molecules in solution and the solid-state10.1155/S1110662X01000277 ↗
25. Perylene diimide derivative dispersed in LDH as a new efficient red-emitting phosphor for LED applications10.1039/D2TC01189A ↗
26. Microstructural changes in SDS micelles induced by hydrotropic salt10.1021/la011435i ↗
27. SERS of the anti-inflammatory drug piroxicam adsorbed on the surface of silver or gold colloids as nanocarrier model10.1002/jrs.4839 ↗
28. Pharmaceutical salts of piroxicam and meloxicam with organic counterions10.1021/acs.cgd.2c00722 ↗
29. Tautomeric transformations of piroxicam in solution: a combined experimental and theoretical study10.1039/C5RA03653D ↗
30. Role of surfactant micellization for enhanced dissolution of poorly water-soluble cilostazol using poloxamer 407-based solid dispersion via the anti-solvent method10.3390/pharmaceutics13050662 ↗
31. Improved solubility and dissolution rate of piroxicam using Gelucire 44/14 and Labrasol10.1016/j.farmac.2005.04.014 ↗
32. The exciton model in molecular spectroscopy10.1351/pac196511030371 ↗
33. Boosting the anticancer activity of doxorubicin with a layered double hydroxide nanocarrier10.1016/j.clay.2021.106000 ↗
34. Excited-state intramolecular proton transfer emission of piroxicam in aqueous β-cyclodextrin solutions
35. Preliminary clinical observations on the use of piroxicam in the management of rectal tubulopapillary polyps10.1111/j.1748-5827.2000.tb03230.x ↗
36. Surface binding studies of spin-labelled piroxicam by electron paramagnetic resonance10.1016/0927-7757(93)80480-3 ↗
37. Lakowicz · 2006
38. Reliability study under thermal and photonic stresses of sulforhodamine B (SRB) confined in layered double hydroxide (LDH)10.1016/j.clay.2020.105922 ↗
39. Synthesis and controlled release properties of prednisone intercalated Mg−Al layered double hydroxide composite10.1021/ie900043r ↗
40. Layered double hydroxides as an intercalation system for hydrophobic molecules10.3390/nano13243145 ↗
42. Layered double hydroxides: a brief review from fundamentals to application as evolving biomaterials10.1016/j.clay.2017.12.021 ↗
43. Intercalation of amino acids and peptides into Mg–Al layered double hydroxide by reconstruction method10.1016/j.ijpharm.2003.09.043 ↗
44. Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: Enhanced efficacy due to clathrin-mediated endocytosis10.1021/bc0601323 ↗
45. Spectroscopic characterization and general features of piroxicam encapsulated in nanostructured lipid carriers10.1016/j.colsurfa.2021.126340 ↗
46. Insight into the solubility and dissolution behavior of piroxicam anhydrate and monohydrate forms10.1016/j.ijpharm.2012.04.042 ↗
47. Surface modification of two-dimensional layered double hydroxide nanoparticles with biopolymers for biomedical applications10.1016/j.addr.2022.114590 ↗
48. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam10.1016/j.ijpharm.2005.05.032 ↗
49. Piroxicam, a traditional non-steroidal anti-inflammatory drug (NSAID) causes apoptosis by ROS-mediated Akt activation10.1016/j.pharep.2015.05.012 ↗
50. Bio-inorganic layered double hydroxide nanohybrids in Photochemotherapy: a mini review10.3390/ijms231911862 ↗
51. Micellar dipolar rearrangement is sensitive to hydrophobic chain length: Implication for structural switchover of piroxicam10.1016/j.chemphyslip.2016.09.001 ↗
52. Polymorphism in piroxicam10.1021/cg049876y ↗
53. Experimental electron densities of neutral and zwitterionic forms of piroxicam drug10.1039/C5CE02397A ↗
54. Anionic surfactant enhanced phosphate desorption from Mg/Al-layered double hydroxides by micelle formation10.1016/j.jcis.2013.08.040 ↗
55. Compatibility studies between piroxicam and pharmaceutical excipients used in solid dosage forms10.1007/s11094-008-0091-0 ↗
56. Influence of environment on piroxicam polymorphism: vibrational spectroscopic study10.1002/1097-0282(2001)62:1<68::AID-BIP80>3.0.CO;2-X ↗
57. Tailoring hybrid layered double hydroxides for the development of innovative applications10.1002/adfm.201703868 ↗
58. Layered double hydroxide materials: Assembly and photofunctionality
59. Template occluded SBA-15: an effective dissolution enhancer for poorly water-soluble drug10.1016/j.apsusc.2010.05.007 ↗
60. Thermal stability of piroxicam part 2. Kinetic study of the active substance under isothermal conditions10.1007/s10973-013-2979-5 ↗
61. Rapid sublingual delivery of piroxicam from electrospun cyclodextrin inclusion complex nanofibers10.1021/acsomega.2c03987 ↗
62. Intercalation of hydrophilic and hydrophobic antibiotics in layered double hydroxides10.1016/j.ijpharm.2006.09.031 ↗
63. Layered particle-based polymer composites for coatings: part I. Evaluation of layered double hydroxides10.1016/j.porgcoat.2008.09.021 ↗
64. Nanobiohybrids as delivery vehicles for camptothecin10.1016/j.jconrel.2003.12.027 ↗
65. Valeur · 2012
66. A first wide-open LDH structure hosting InP/ZnS QDs: a new route toward efficient and photostable red-emitting phosphor
67. Thermal decomposition mechanism of piroxicam10.1007/s10973-018-7308-6 ↗
68. Facile synthesis of camptothecin intercalated layered double hydroxide nanohybrids via a coassembly route10.1016/j.ijpharm.2013.06.043 ↗
69. Sulforhodamine B intercalated layered double hydroxide thin film with polarized photoluminescence10.1021/jp8084217 ↗
70. Proton transfer equilibria in the excited state of piroxicam and its analog in aqueous solution
71. Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: in vitro and in vivo evaluation10.1016/S0939-6411(03)00142-5 ↗
72. Efficient dispersion of organic fluorophores by size matching with a difunctionalized spacer interleaved into layered double hydroxide10.1021/acsaom.3c00173 ↗
73. Na-dodecylsulfate modification of hydrocalumite and subsequent effect on the structure and thermal decomposition10.1007/s10973-010-1001-8 ↗
74. Glycineand alanine-intercalated layered double hydroxides as highly efficient adsorbents for phosphate with kinetic advantages10.3390/nano12040586 ↗
75. Effect of the surfactant on the availability of piroxicam as a poorly hydrosoluble drug from suppositories